Success Metrics

Clinical Success Rate
87.5%

Based on 223 completed trials

Completion Rate
87%(223/255)
Active Trials
83(19%)
Results Posted
43%(97 trials)
Terminated
32(7%)

Phase Distribution

Ph phase_1
18
4%
Ph phase_3
34
8%
Ph phase_4
8
2%
Ph not_applicable
323
72%
Ph phase_2
60
13%
Ph early_phase_1
3
1%

Phase Distribution

21

Early Stage

60

Mid Stage

42

Late Stage

Phase Distribution446 total trials
Early Phase 1First-in-human
3(0.7%)
Phase 1Safety & dosage
18(4.0%)
Phase 2Efficacy & side effects
60(13.5%)
Phase 3Large-scale testing
34(7.6%)
Phase 4Post-market surveillance
8(1.8%)
N/ANon-phased studies
323(72.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.8%

223 of 263 finished

Non-Completion Rate

15.2%

40 ended early

Currently Active

83

trials recruiting

Total Trials

447

all time

Status Distribution
Active(106)
Completed(223)
Terminated(40)
Other(78)

Detailed Status

Completed223
unknown74
Recruiting71
Terminated32
Not yet recruiting21
Active, not recruiting12

Development Timeline

Analytics

Development Status

Total Trials
447
Active
83
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (0.7%)
Phase 118 (4.0%)
Phase 260 (13.5%)
Phase 334 (7.6%)
Phase 48 (1.8%)
N/A323 (72.4%)

Trials by Status

recruiting7116%
active_not_recruiting123%
completed22350%
not_yet_recruiting215%
enrolling_by_invitation20%
unknown7417%
suspended41%
terminated327%
withdrawn82%

Recent Activity

Clinical Trials (447)

Showing 20 of 447 trialsScroll for more
NCT07619989Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists

Recruiting
NCT07592273Phase 2

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Recruiting
NCT07689227Not Applicable

Closed-Loop Vagus Nerve Stimulation (CLV) for Recovery of Gait After Spinal Cord Injury (SCI)

Not Yet Recruiting
NCT07668882Not Applicable

Noninvasive Thalamocortical Neuromodulation With Low-Intensity Focused Ultrasound for Persistent Developmental Stuttering

Not Yet Recruiting
NCT06659445Phase 2

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Recruiting
NCT06443177Not Applicable

The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage

Suspended
NCT04122001Not Applicable

Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease

Active Not Recruiting
NCT07695233Not Applicable

Pedunculopontine Nucleus Transcranial Ultrasound Stimulation as a Treatment of Freezing of Gait in Parkinson's Disease

Recruiting
NCT05580614Not Applicable

Paired tVNS With ERP in OCD

Recruiting
NCT05008315Not Applicable

Effects of Soft Tissue Mobilization on Postsurgical Adhesions, Pain, Lumbopelvic Muscle Functions, Spinal Mobility, and Posture in Postpartum Women With Caesarean Section

Suspended
NCT07680127Not Applicable

TENS of Auricular Vagal Nerve for Radiation Necrosis

Not Yet Recruiting
NCT07681167Phase 2

Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial

Not Yet Recruiting
NCT06876766Not Applicable

Effect of Pediatric Lung Ultrasound on Antibiotic Prescriptions in Hospitalized Children and Adolescents With Lower Respiratory Tract Infections. A Randomized Controlled Trial.

Recruiting
NCT03875326Not Applicable

Stimulation to Improve Memory

Completed
NCT00974415Not Applicable

Study of the Carbon Dioxide Treatment for Fat Reduction

Completed
NCT02922894Phase 4

Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury

Recruiting
NCT06559891Not Applicable

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

Recruiting
NCT03625752Not Applicable

Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain

Active Not Recruiting
NCT06203938Not Applicable

Autism Research Project With Non-Invasive Near-Infrared Light Stimulation

Recruiting
NCT05850520Phase 3

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
447